Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ISOVUE-370

IOPAMIDOL

Standard Dose
76%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ISOVUE-370 is listed in Drugs@FDA under application 018735 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IOPAMIDOL Form and strength INJECTABLE;INJECTION - 76% Sponsor BRACCO Submission history Latest submission status date: 2026-01-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview ISOVUE-370 is listed in Drugs@FDA under application 018735 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IOPAMIDOL Form and strength INJECTABLE;INJECTION - 76% Sponsor BRACCO Submission history Latest submission status date: 2026-01-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.